How would you present the product profile of topical roflumilast to HCP colleagues who are reluctant due to poor prior experience with other PDE4 inhibitors?
Featuring Peter Lio, MD |
Clinical Assistant Professor of Dermatology Pediatrics | Published June 29, 2023
Clinical Assistant Professor of Dermatology Pediatrics
Northwestern University Feinberg School of Medicine